The 2023 NTI Nuclear Security Index
“The bottom line is that the countries and areas with the greatest responsibility for protecting the world from a catastrophic act of nuclear terrorism are derelict in their duty,” the 2023 NTI Index reports.
Joan Rohlfing and James McKeon in USA Today: “Our nuclear weapons are much more powerful than Oppenheimer’s atomic bomb.”
Today, we have the capability to monitor and control nuclear weapons technologies that didn’t yet exist in Oppenheimer’s time.
“Oppenheimer” and Nuclear Risks Today
Christopher Nolan's Oppenheimer is the most high-profile film about nuclear weapons ever made.
Preventing the Next Biological Catastrophe: A Tabletop Exercise Summary
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Ernest J. Moniz in Foreign Policy: “A Nuclear South Korea is a Dangerous Miscalculation.”
At their upcoming summit, Biden needs to let Yoon know there would be consequences for breaking Seoul’s nonproliferation promises.
Joan Rohlfing on “The Myth of ‘Just’ Nuclear Deterrence.”
We owe the future a new nuclear security strategy that can prevent an existential global nuclear event.
Ernest J. Moniz and Sam Nunn on “Confronting the New Nuclear Peril”
NTI Board Co-Chair and CEO Ernest J. Moniz and NTI Board Co-Chair Sam Nunn have co-authored an article in Foreign Affairs about the need to find new avenues for preventing nuclear weapons use at an increasingly dangerous time.
The Biorisk Management Casebook: Insights into Contemporary Practices
Practical solutions for organizations involved in life science research to manage risks and prevent accidents, misuse, and other adverse outcomes stemming from their work.
Angela Kane and Jaime Yassif on Discerning “Where the Next Pandemic Will Come From”
In an op-ed for The Hill, NTI Senior Advisor Angela Kane and Vice President for Global Biological Policy and Programs Jaime Yassif acknowledge the importance of the ongoing investigation into the source of the COVID-19 pandemic.